{"id":1092,"date":"2024-05-27T09:45:14","date_gmt":"2024-05-27T09:45:14","guid":{"rendered":"https:\/\/amm-journal.org\/?p=1092"},"modified":"2024-05-27T09:45:41","modified_gmt":"2024-05-27T09:45:41","slug":"the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation","status":"publish","type":"post","link":"https:\/\/amm-journal.org\/index.php\/2024\/05\/27\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\/","title":{"rendered":"The andrographolide derivative, AND7, and TRAIL combination attenuates acute lymphoblastic leukemia through P53-regulated ROS accumulation"},"content":{"rendered":"

Announcing a new publication for Acta Materia Medica<\/em> journal. Acute lymphoblastic leukemia (ALL) is a malignant disease of the hematologic system. The current treatment is based on chemotherapeutic drugs, which are becoming less effective due to drug resistance. TNF-related apoptosis-inducing ligand (TRAIL) is an apoptotic protein used to treat cancer that does not affect healthy cells. In recent years, however, ALL cells (e.g., U937) have become more resistant to TRAIL. A novel andrographolide derivative (AND7) with high efficiency and low toxicity was synthesized and combined with TRAIL after the optimal combination ratio was screened using U937 cells. The authors of this article used peripheral blood mononuclear cells (PBMCs) from patients before the initial treatment of ALL as a model and PBMCs from healthy subjects as a control to determine the mechanism underlying ALL treatment. AND7\/TRAIL combination treatment was shown to prevent the original TRAIL-resistant cells from activating the caspase-8\/caspase-3 pathway through DR4\/DR5 and promote apoptosis via expression of ROS and the apoptotic gene, P53, to achieve an anti-cancer effect.<\/p>\n

This study demonstrates that the AND7\/TRAIL combination enhanced the anti-cancer effect of AND7 and improved TRAIL resistance. Therefore, the AND7\/TRAIL combination is promising for treating ALL and lays the foundation for clinical research.<\/p>\n

https:\/\/www.scienceopen.com\/hosted-document?doi=10.15212\/AMM-2024-0008<\/a><\/p>\n

Acta Materia Medica<\/em> welcomes the submission of research articles, review articles, databases, mini reviews, commentaries, editorials, short communications, case report articles and study protocols.<\/p>\n

Submission Process<\/strong><\/p>\n

Submissions to Acta Materia Medica<\/em> are made using ScholarOne, the online submission and peer review system. Registration and access are available at https:\/\/mc04.manuscriptcentral.com\/ammed<\/a><\/p>\n

Queries about the journal can be sent to editorialoffice@amm-journal.org.<\/p>\n

Please visit https:\/\/amm-journal.org\/<\/a> to learn more about the journal.<\/p>\n

Editorial Board:<\/strong> https:\/\/amm-journal.org\/index.php\/editorial-board\/<\/a><\/p>\n

There are no author submission or article processing fees.<\/p>\n

Follow Acta Materia Medica <\/em><\/strong>on Twitter https:\/\/twitter.com\/AMM_journal<\/a>; Facebook<\/a> (https:\/\/www.facebook.com\/AMMjournal<\/a>)<\/p>\n

eISSN <\/strong>2737-7946<\/p>\n

Letian Xu, Yuting Zhou and Rui Ma et al. The andrographolide derivative, AND7, and TRAIL combination attenuates acute lymphoblastic leukemia through P53-regulated ROS accumulation.\u00a0Acta Materia Medica.\u00a0<\/em>2024. Vol. 3(2):147-162. DOI: 10.15212\/AMM-2024-0008<\/p>\n","protected":false},"excerpt":{"rendered":"

Announcing a new publication for Acta Materia Medica journal. Acute lymphoblastic leukemia (ALL) is a malignant disease of the hematologic system. The current treatment is based on chemotherapeutic drugs, which are becoming less effective due to drug resistance. TNF-related apoptosis-inducing ligand (TRAIL) is an apoptotic protein used to treat cancer that does not affect healthy […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[286,287,288,289],"class_list":["post-1092","post","type-post","status-publish","format-standard","hentry","category-news-and-events","tag-acute-lymphoblastic-leukemia","tag-all","tag-chemotherapeutic-drugs","tag-leukemia"],"yoast_head":"\nThe andrographolide derivative, AND7, and TRAIL combination attenuates acute lymphoblastic leukemia through P53-regulated ROS accumulation - AMM Journal<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/amm-journal.org\/index.php\/2024\/05\/27\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The andrographolide derivative, AND7, and TRAIL combination attenuates acute lymphoblastic leukemia through P53-regulated ROS accumulation - AMM Journal\" \/>\n<meta property=\"og:description\" content=\"Announcing a new publication for Acta Materia Medica journal. Acute lymphoblastic leukemia (ALL) is a malignant disease of the hematologic system. The current treatment is based on chemotherapeutic drugs, which are becoming less effective due to drug resistance. TNF-related apoptosis-inducing ligand (TRAIL) is an apoptotic protein used to treat cancer that does not affect healthy […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/amm-journal.org\/index.php\/2024\/05\/27\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\/\" \/>\n<meta property=\"og:site_name\" content=\"AMM Journal\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-27T09:45:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-27T09:45:41+00:00\" \/>\n<meta name=\"author\" content=\"Compuscript\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Compuscript\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2024\\\/05\\\/27\\\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2024\\\/05\\\/27\\\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\\\/\"},\"author\":{\"name\":\"Compuscript\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/0935dba5c919585e39f756ce09930a67\"},\"headline\":\"The andrographolide derivative, AND7, and TRAIL combination attenuates acute lymphoblastic leukemia through P53-regulated ROS accumulation\",\"datePublished\":\"2024-05-27T09:45:14+00:00\",\"dateModified\":\"2024-05-27T09:45:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2024\\\/05\\\/27\\\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\\\/\"},\"wordCount\":376,\"commentCount\":0,\"keywords\":[\"Acute lymphoblastic leukemia\",\"ALL\",\"chemotherapeutic drugs\",\"leukemia\"],\"articleSection\":[\"News and Events\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2024\\\/05\\\/27\\\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2024\\\/05\\\/27\\\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\\\/\",\"url\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2024\\\/05\\\/27\\\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\\\/\",\"name\":\"The andrographolide derivative, AND7, and TRAIL combination attenuates acute lymphoblastic leukemia through P53-regulated ROS accumulation - AMM Journal\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#website\"},\"datePublished\":\"2024-05-27T09:45:14+00:00\",\"dateModified\":\"2024-05-27T09:45:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/0935dba5c919585e39f756ce09930a67\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2024\\\/05\\\/27\\\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2024\\\/05\\\/27\\\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2024\\\/05\\\/27\\\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/amm-journal.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The andrographolide derivative, AND7, and TRAIL combination attenuates acute lymphoblastic leukemia through P53-regulated ROS accumulation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#website\",\"url\":\"https:\\\/\\\/amm-journal.org\\\/\",\"name\":\"AMM Journal\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/amm-journal.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/0935dba5c919585e39f756ce09930a67\",\"name\":\"Compuscript\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g\",\"caption\":\"Compuscript\"},\"sameAs\":[\"https:\\\/\\\/amm-journal.org\"],\"url\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/author\\\/ammjadmin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The andrographolide derivative, AND7, and TRAIL combination attenuates acute lymphoblastic leukemia through P53-regulated ROS accumulation - AMM Journal","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/amm-journal.org\/index.php\/2024\/05\/27\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\/","og_locale":"en_GB","og_type":"article","og_title":"The andrographolide derivative, AND7, and TRAIL combination attenuates acute lymphoblastic leukemia through P53-regulated ROS accumulation - AMM Journal","og_description":"Announcing a new publication for Acta Materia Medica journal. Acute lymphoblastic leukemia (ALL) is a malignant disease of the hematologic system. The current treatment is based on chemotherapeutic drugs, which are becoming less effective due to drug resistance. TNF-related apoptosis-inducing ligand (TRAIL) is an apoptotic protein used to treat cancer that does not affect healthy […]","og_url":"https:\/\/amm-journal.org\/index.php\/2024\/05\/27\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\/","og_site_name":"AMM Journal","article_published_time":"2024-05-27T09:45:14+00:00","article_modified_time":"2024-05-27T09:45:41+00:00","author":"Compuscript","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Compuscript","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/amm-journal.org\/index.php\/2024\/05\/27\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\/#article","isPartOf":{"@id":"https:\/\/amm-journal.org\/index.php\/2024\/05\/27\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\/"},"author":{"name":"Compuscript","@id":"https:\/\/amm-journal.org\/#\/schema\/person\/0935dba5c919585e39f756ce09930a67"},"headline":"The andrographolide derivative, AND7, and TRAIL combination attenuates acute lymphoblastic leukemia through P53-regulated ROS accumulation","datePublished":"2024-05-27T09:45:14+00:00","dateModified":"2024-05-27T09:45:41+00:00","mainEntityOfPage":{"@id":"https:\/\/amm-journal.org\/index.php\/2024\/05\/27\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\/"},"wordCount":376,"commentCount":0,"keywords":["Acute lymphoblastic leukemia","ALL","chemotherapeutic drugs","leukemia"],"articleSection":["News and Events"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/amm-journal.org\/index.php\/2024\/05\/27\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/amm-journal.org\/index.php\/2024\/05\/27\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\/","url":"https:\/\/amm-journal.org\/index.php\/2024\/05\/27\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\/","name":"The andrographolide derivative, AND7, and TRAIL combination attenuates acute lymphoblastic leukemia through P53-regulated ROS accumulation - AMM Journal","isPartOf":{"@id":"https:\/\/amm-journal.org\/#website"},"datePublished":"2024-05-27T09:45:14+00:00","dateModified":"2024-05-27T09:45:41+00:00","author":{"@id":"https:\/\/amm-journal.org\/#\/schema\/person\/0935dba5c919585e39f756ce09930a67"},"breadcrumb":{"@id":"https:\/\/amm-journal.org\/index.php\/2024\/05\/27\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/amm-journal.org\/index.php\/2024\/05\/27\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/amm-journal.org\/index.php\/2024\/05\/27\/the-andrographolide-derivative-and7-and-trail-combination-attenuates-acute-lymphoblastic-leukemia-through-p53-regulated-ros-accumulation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/amm-journal.org\/"},{"@type":"ListItem","position":2,"name":"The andrographolide derivative, AND7, and TRAIL combination attenuates acute lymphoblastic leukemia through P53-regulated ROS accumulation"}]},{"@type":"WebSite","@id":"https:\/\/amm-journal.org\/#website","url":"https:\/\/amm-journal.org\/","name":"AMM Journal","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/amm-journal.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/amm-journal.org\/#\/schema\/person\/0935dba5c919585e39f756ce09930a67","name":"Compuscript","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g","caption":"Compuscript"},"sameAs":["https:\/\/amm-journal.org"],"url":"https:\/\/amm-journal.org\/index.php\/author\/ammjadmin\/"}]}},"_links":{"self":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/1092","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/comments?post=1092"}],"version-history":[{"count":2,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/1092\/revisions"}],"predecessor-version":[{"id":1094,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/1092\/revisions\/1094"}],"wp:attachment":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/media?parent=1092"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/categories?post=1092"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/tags?post=1092"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}